Dr. George Ebers of UK's prestigious Oxford University when he states in a presentation from October 17, 2013 to the European Medicines Agency- "We must stop marketers from misleading patients and families that RR drugs prevent disability". See video @ 14:19 (https://www.youtube.com/watch?v=OqY-_K1fYJY).

As an MS patient myself, I cannot tell you the number of times from neurologists that this class of medications does indeed prevent disability. This is clearly misleading patients and giving them false hope where no hope is due!














Critical review of outcomes used in MS clinical trials





youtube.com

Speaker: George Ebers, John Radcliffe Hospital Session 1: New outcome measures in multiple sclerosis Workshop on the clinical investigation of new medicines ...